Signal Transducer and Activator of Transcription 3 (STAT3) Inhibitors -Pipeline Insights, 2015

 
NEW DELHI - Aug. 7, 2015 - PRLog -- DelveInsight, the leading market research company has added new report “Signal Transducer and Activator of Transcription 3 (STAT3) Inhibitors -Pipeline Insights, 2015” to its portfolio. With this launch Delveinsight now has 700+ Reports on Mechanism of Action (MOA) Pipeline Insight. DelveInsight is the only company that promulgates Mechanism of Action (MOA) Pipeline Insight Reports. In addition to this our research expertise provides our clients with up to date information of market till date order.

The market is still dormant but pipeline is pitching and the market is expected to rise with the launch of several pipeline drugs in a few years. The “Signal Transducer and Activator of Transcription 3 (STAT3) Inhibitors -Pipeline Insights, 2015” report will help companies to optimize their portfolio by analyzing the market and creating effective counter-strategies for collaborations and licensing deals. In addition to this report on “Signal Transducer and Activator of Transcription 3 (STAT3) Inhibitors -Pipeline Insights, 2015”. Report also gives the information about:

·  •  Therapeutic targets and their mechanism of action (MOA) according to latest R&D, pipeline products, technologies, clinical profiling, molecule type and stages of development.

·   •  Information on collaborations and in-licensing & out-licensing deals.

·   • Information on 17 Pipeline drugs which includes 1 in PhaseIII, 1 Phase2/3, 6 Phase II, 3 PhaseI, 7 Pre-clinical and 2 in discovery along with 1 discontinued and 2 Inactive along with 21 active companies .

·  • Boston Biomedical Inc has developed Napabucasin (BBI608. Drug is under Phase III clinical trial.

DelveInsight is offering the Report at a price of USD 1250 as a single user license, USD 2500 as a site license and USD 4000 as a Global/Enterprise License.

About
DelveInsight is a leading Business Consulting and Market Research Firm.  We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. In addition to this DelveInsight also deals in providing custom research services in coherence with interest area of the clients.

Contact
delveInsight
***@delveinsight.com
End
Source: » Follow
Email:***@delveinsight.com Email Verified
Tags:DelveInsight, Indication Pipeline Insight, Collaborations, STAT3, Napabucasin
Industry:Business
Location:New Delhi - Delhi - India
Subject:Products
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
DelveInsight PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share